Viewing Study NCT03646994


Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2026-01-06 @ 10:11 PM
Study NCT ID: NCT03646994
Status: RECRUITING
Last Update Posted: 2023-12-27
First Post: 2018-08-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Real World Study on First Line Crizotinib in ROS1 Rearranged Advanced Non-squamous Non-small Cell Lung Cancer
Sponsor: Hunan Province Tumor Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module